Premium
Inoviq Ltd (IIQ)
ASX
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; ... INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.175 | 46.0526315789 | 0.38 | 0.565 | 0.375 | 881519 | 0.47630033 | DE |
| 4 | 0.23 | 70.7692307692 | 0.325 | 0.565 | 0.295 | 373574 | 0.43239468 | DE |
| 12 | 0.225 | 68.1818181818 | 0.33 | 0.565 | 0.295 | 173375 | 0.40072229 | DE |
| 26 | 0.19 | 52.0547945205 | 0.365 | 0.565 | 0.295 | 151765 | 0.3794563 | DE |
| 52 | 0.175 | 46.0526315789 | 0.38 | 0.565 | 0.295 | 145663 | 0.37343913 | DE |
| 156 | 0.05 | 9.90099009901 | 0.505 | 0.99 | 0.295 | 132434 | 0.49438869 | DE |
| 260 | -0.515 | -48.1308411215 | 1.07 | 1.285 | 0.295 | 118551 | 0.54885428 | DE |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
